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GUIDELINES
Managing the long term effects of covid-19: summary of NICE, SIGN,
and RCGP rapid guideline
Waqaar Shah, 1 Toby Hillman, 2 E Diane Playford, 3 Lyth Hishmeh
What you need to know
• The likelihood of developing long term effects of
covid-19 is not thought to be related to the severity
of the acute infection
• The most common symptoms of long term covid-19
are fatigue and breathlessness. Symptoms may be
singular, multiple, constant, transient, or fluctuating,
and can change in nature over time
• Offer a chest radiograph by 12 weeks after acute
covid-19 if the person has not had one already and
has continuing respiratory symptoms
For a proportion of people covid-19 leads to long term
effects that can have a significant impact on quality
of life. According to the Office for National Statistics,
aroundone in five people testing positive for covid-19
exhibit symptoms for a period of five weeks or more.1
Thispresents challenges fordeterminingbest-practice
standards of care. As yet, no commonly agreed
clinical definition of long term covid-19 exists, nor a
clear definition of treatment pathway. To assist
clinicians, the National Institute for Health and Care
Excellence (NICE), the Scottish Intercollegiate
Guidelines Network (SIGN), and the Royal College of
General Practitioners (RCGP) have developed the
“COVID-19 rapid guideline: managing the long term
effects of COVID-19.”2 It covers care for people with
signs and symptoms that continue for more than four
weeks, and which developed during or after an
infection consistent with covid-19, and which are not
explained by alternative diagnoses.
The guideline provides clinical definitions of the
effects of covid-19 at different times and provides
advice on diagnosis and management based on the
best available evidence and the knowledge and
experience of the expert panel. It will be subject to a
“living” approach, which means that targeted areas
of the guidelinewill be reviewedweekly andupdated
in response to emerging evidence andevolving expert
experience. This article summarises the guideline
recommendations aspublishedon 18December 2020,
with particular emphasis on primary care. Updates
are available on the NICE website.2
Recommendations
The guideline is part of a series of rapid guidelines
on covid-19.3 Available evidencewas of poor quality,
unsurprisingly given the novel nature of this
condition, and recommendations were made mainly
based on expert opinion.
Definitions
The guideline defines acute covid-19, ongoing
symptomatic covid-19, and post-covid-19 syndrome,
according to duration of symptoms. The guideline
acknowledges common usage of “long covid,” but
thepanel felt discrete, time-bound termswouldbetter
facilitate access to support, provide the basis for
service planning, and enable clinical datasets to be
established for monitoring and research. Box 1 gives
definitions.
Box 1: Covid-19 definitions
• Acute covid-19 infection—Signs and symptoms of
covid-19 for up to four weeks
• Ongoing symptomatic covid-19—Signs and symptoms
of covid-19 present from four weeks and up to 12
weeks
• Post-covid-19 syndrome—Signs and symptoms that
develop during or after an infection consistent with
covid-19, present for more than 12 weeks and are not
attributable to alternative diagnoses
Identifying people with ongoing symptomatic
covid-19 or post-covid-19 syndrome
Theguidelinemakes recommendations forhealthcare
professionals caring for people who have had
suspected or confirmed acute covid-19 and present
to anyhealthcare setting, irrespective ofwhether they
were hospitalised or had a positive or negative
SARS-CoV-2 test (polymerase chain reaction, antigen,
or antibody). The guideline emphasises providing
information to empower people to understand their
symptoms, and to recognise when to seek help.
• Give peoplewhohavehad suspected or confirmed
acute covid-19 (and their families or carers, as
appropriate) advice and written information on
‐ the most common new or ongoing symptoms
after acute covid-19
‐ what they might expect during their recovery,
including that:
  recovery time is different for everyone, but
for many people symptoms will resolve by
12 weeks
  the likelihood of developing ongoing
symptomatic covid-19 or post-covid-19
syndrome is not thought to be linked to the
severity of their acute covid-19 (including
whether they were in hospital)
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  if new or ongoing symptoms occur they can change
unpredictably, affecting people in different ways at
different times
‐ how to self-manage ongoing symptomatic covid-19 or
post-covid-19 syndrome
‐ symptoms to look out for that mean they should contact their
healthcare professional
‐ who to contact if they are worried about new, ongoing, or
worsening symptoms, especially if they have themmore than
four weeks after the start of acute covid-19.
• For people who are concerned about new or ongoing symptoms
four weeks or more after acute covid-19, offer an initial
consultation and use shared decision making to discuss and
agree with the person whether the meeting should be by video,
phone, or in person.
Support people in underserved or vulnerable groups to access
assessment and care by (for example) raising awareness about the
long termeffects of covid-19, andproviding extra timeor additional
support (such as an interpreter or advocate) during consultations.
Consider follow-up for people in vulnerable groups who have
self-managed in the community after suspected or confirmed acute
covid-19.
Assessing people with new or ongoing symptoms after acute
covid-19
The most common symptoms are fatigue and breathlessness. Other
possible symptoms are listed in box 2. Symptoms may be singular,
multiple, constant, transient, or fluctuating, and can change in
nature over time. Assessment should include physical, cognitive,
psychological, and psychiatric symptoms, as well as functional
abilities.
Box 2: Possible symptoms after acute covid-19
Symptoms are highly variable and wide ranging. The most commonly

















• Peripheral neuropathy symptoms (pins and needles and numbness)
• Dizziness










• Symptoms of depression
• Symptoms of anxiety




• Loss of taste and/or smell
Dermatological
• Skin rashes
• Include in the comprehensive clinical history:
‐ history of suspected or confirmed acute covid-19
‐ the nature and severity of previous and current symptoms
‐ timing and duration of symptoms since the start of acute
covid-19
‐ history of other health conditions.
• Discuss how the person’s life and activities, for example their
work or education, mobility, and independence, have been
affected by ongoing symptomatic covid-19 or suspected
post-covid-19 syndrome.
• Discuss the person’s experience of their symptomsandask about
any feelings of worry or distress. Listen to their concerns with
empathy and acknowledge the impact of the illness on their
day-to-day life, for example, activities of daily living, feelings of
social isolation, work and education, and wellbeing.
• Donot predictwhether a person is likely to developpost-covid-19
syndrome based on whether they had certain symptoms (or
clusters of symptoms) or were in hospital during acute covid-19.
• When investigating possible causes of a gradual decline,
deconditioning, worsening frailty or dementia, or loss of interest
in eating and drinking in older people, bear in mind that these
can be signs of ongoing symptomatic covid-19 or suspected
post-covid-19 syndrome.
Investigation and referral
Covid-19may cause complications suchasmyocarditis andpostural
hypotension. However, not all symptoms will be related to covid-19.
Investigations serve to rule out serious or urgent complications,
evaluate symptoms secondary to ongoing symptomatic covid-19 or
post-covid-19 syndrome, or to look for new, unrelated diagnoses.
No one set of investigations and testswould be suitable for everyone
because of the wide range of symptoms and severity.
• Offer blood tests, which may include a full blood count, kidney
and liver function, C reactive protein, ferritin, B-type natriuretic
peptide, and thyroid function.
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• Offer a chest radiograph by 12 weeks after acute covid-19 if the
person has not had one already and has continuing respiratory
symptoms. Chest radiography appearances alone should not
determine the need for referral for further care. Be aware that a
plain chest radiograph may not be sufficient to rule out lung
disease.
• If appropriate, offer an exercise tolerance test suited to the
person’s ability (for example the 1 minute sit-to-stand test).
During the exercise test, record level of breathlessness, heart
rate, and oxygen saturation. Follow an appropriate protocol to
carry out the test safely.
• For people with postural symptoms, for example palpitations or
dizziness on standing, carry out lying and standing blood
pressure and heart rate recordings (3 minute active stand test,
or 10 minutes if you suspect postural tachycardia syndrome, or
other forms of autonomic dysfunction).
• Refer people with ongoing symptomatic covid-19 or suspected
post-covid-19 syndrome urgently to the relevant acute services
if they have signs or symptoms that could be caused by an acute
or life threatening complication, including (but not limited to):
‐ severe hypoxaemia or oxygen desaturation on exercise
‐ signs of severe lung disease
‐ cardiac chest pain
‐ multisystem inflammatory syndrome (in children).
• After ruling out acute or life threatening complications and
alternative diagnoses, consider referring people to an integrated
multidisciplinary assessment service (if available) any time from
four weeks after the start of acute covid-19.
Planning care
• After the holistic assessment, use shared decision making to
discuss and agree with the person (and their family or carers, if
appropriate) what support and rehabilitation they need and how
this will be provided. This should include:
‐ advice on self-management, with the option of supported
self-management, and one of the following, depending on
clinical need and local pathways:
  support from integrated and coordinated primary care,
community, rehabilitation, and mental health services
  referral to an integrated multidisciplinary assessment
service
  referral to specialist care for specific complications.
• Whendiscussingwith theperson the appropriate level of support
and management:
‐ think about the overall impact their symptoms are having on
their life, even if each individual symptom alone may not
warrant referral
‐ look at the overall trajectory of their symptoms, taking into
account that symptoms often fluctuate and recur, so they
might need different levels of support at different times.
Management
Theguideline offers anoverviewof self-management and supported
self-management. Patient organisations and online support groups
can help support self-management.
• Give advice and information on self-management to peoplewith
ongoing symptomatic covid-19 or post-covid-19 syndrome,
starting from their initial assessment. This should include:
‐ ways to self-manage their symptoms, such as setting realistic
goals
‐ who to contact if they are worried about their symptoms or
they need support with self-management
‐ sources of advice and support, including support groups,
social prescribing, online forums, and apps
‐ how to get support from other services, including social care,
housing, andemployment, andadvice about financial support
‐ information about new or continuing symptoms of covid-19
that theperson can sharewith their family, carers, and friends.
• Support people in discussions with their employer, school, or
college about returning to work or education, for example by
having a phased return.
Basedon their experience, the guideline panel agreed that symptom
diaries and symptom tracking apps can be helpful for
self-monitoring. The evidence for different symptom tracking apps
was not reviewed, so the panel could not recommend a specific
product. TheNHSwebsite “YourCOVIDRecovery”4 washighlighted
as apotential source of reliable, up-to-date informationand support.
Thepanel agreed thatmultidisciplinary rehabilitation teams should
work with people to make a plan for their rehabilitation once any
symptoms that could affect the safety of rehabilitation have been
investigated. Physical, psychological, and psychiatric aspects of
rehabilitation should be addressed, and management of fatigue
should be a key component of this. The evidence showed that
breathlessness, fatigue, and “brain fog” are among the most
commonly reported long termsymptoms, so support for these should
be part of the person’s rehabilitation plan.
Follow-up and monitoring
• Agree with the person how often follow-up and monitoring are
needed and which healthcare professionals should be involved.
• Using shared decision making, offer people the option of
monitoring in person or remotely depending on availability, the
person’s preference, andwhether it is clinically suitable for them.
• Tailor monitoring to the person’s symptoms and discuss any
changes, including new or worsening symptoms and the effects
of these on the person’s life and wellbeing.
Sharing information and continuity of care
Thepanel foundevidence that somepeoplehave struggled to access
appropriate care, and some had experienced fragmented care.
• Ensure effective information sharing and integrated working by
sharing clinical records and plans for care and rehabilitation
promptly between services and through multidisciplinary
meetings, either virtually or in person.
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• Give the person a copy of their care plans or records to keep,
including their discharge letters, clinical records, and
rehabilitation plans and prescriptions.
• Include baseline measures as well as ongoing assessments in
information sharedbetween services, includingwhen theperson
is discharged from hospital. For example, resting oxygen
saturation and heart rate, and the results of functional
assessment.
• Provide continuity of care with the same healthcare professional
or team as much as possible, for example, by providing a care
co-ordinator or a single point of contact.
Service organisation
The guideline makes recommendations about the provision of, and
access to multidisciplinary services. The panel agreed that some of
the common elements, such as integration and multidisciplinary
team working, would help provide effective, well organised care
for people with ongoing symptomatic covid-19 and post-covid-19
syndrome.Aswell as ensuring the right breadth of expertise, having
a multidisciplinary team with input from other services and a clear
referral pathways can prevent disjointed care and people waiting
a long time for appointments with multiple specialists.
Differential access may be affected, for example, by age, race,
disability, homelessness, language, digital accessibility,
socioeconomic factors, and mental health conditions.
• Deploy multidisciplinary clinics (possibly using the “one-stop”
clinic model) to assess physical and mental health symptoms
and to conduct appropriate investigations.
• For rehabilitation, supply an integrated, multidisciplinary
service, based on local need and resources. A range of specialists
should be available, especially for expertise in treating fatigue
and respiratory symptoms (includingbreathlessness); additional
expertise may be sourced depending on the age and symptoms
of the person.
• To ensure seamless care, referral pathways need to be integrated
between primary and community care, multidisciplinary
rehabilitation services, and specialist services, multidisciplinary
assessment clinics, and specialist mental health services.
Guidelines into practice
• Patients with long term effects of covid-19 have symptoms that
resemble a wide range of other conditions. Do we always have this
in mind when managing the patient?
• People living with long term effects of covid-19 often experience
misunderstanding from relatives, friends, and colleagues. How can
we best help them manage the uncertainty associated with this
condition, and avoid feeling dismissed or ignored?
How patients were involved in the creation of this article
Six members of the expert advisory panel involved in creating this
guideline had experienced long term effects of covid-19. A lay member
of the expert advisory panel is co-author of this paper.
These contributors reported that they sometimes felt dismissed and
misunderstood by healthcare professionals when they reported long term
symptoms. We considered this insight when preparing the sections of
this article on referral and management.
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